12:00 AM
Nov 19, 2012
 |  BC Week In Review  |  Company News  |  Deals

TiGenix, Genpharm Services deal

TiGenix granted pharmaceutical marketing company Genpharm exclusive rights to develop and commercialize ChondroCelect in Saudi Arabia, the United Arab Emirates, Kuwait, Bahrain, Qatar, Oman,...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >